Genetic ablation of PLAG6 in mice leads to cerebellar atrophy characterized by purkinje cell loss and glial cell activation

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Zhao, Zhengshan ^a   Wang, Jing ^a   Zhao, Chunying ^a   Bi, Weina ^a   Yue, Zhenyu ^a   Ma, Zhongmin Alex ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; PHOSPHOLIPASE A2 GROUP VI; TUMOR NECROSIS FACTOR ALPHA; PLA2G6 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CELL ACTIVATION; CELL LOSS; CEREBELLUM ATROPHY; CONTROLLED STUDY; DEVELOPMENTAL GENE; ENCEPHALITIS; GENE EXPRESSION; GENETIC ABLATION; GENETIC PROCEDURES; GLIA CELL; HUMAN; IMMUNOPATHOGENESIS; MICROGLIA; MOUSE; NEUROAXONAL DYSTROPHY; NONHUMAN; PLA2G6 GENE; PROMOTER REGION; PURKINJE CELL; UPREGULATION; ANIMAL; ATROPHY; CEREBELLUM DISEASE; GENETICS; GLIA; IMMUNOLOGY; PATHOLOGY;

EPICOCCUM; MUS;

ANIMALS; ATROPHY; CEREBELLAR DISEASES; GROUP VI PHOSPHOLIPASES A2; INTERLEUKIN-1BETA; MICE; MICROGLIA; NEUROAXONAL DYSTROPHIES; NEUROGLIA; PURKINJE CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80055026001     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026991     Document Type: Article

References (48)

1. 2. Prog Nucleic Acid Res Mol Biol 67: 1-33.
2. 2 gene on chromosome 22q13.1. J Biol Chem 274: 9607-9616.
3. 2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet 38: 752-754.
4. 2. Neurology 71: 1402-1409.
5. Khateeb S, Flusser H, Ofir R, Shelef I, Narkis G, et al. (2006) PLAG6 mutation underlies infantile neuroaxonal dystrophy. Am J Hum Genet 79: 942-948.
6. Kurian MA, Morgan NV, MacPherson L, Foster K, Peake D, et al. (2008) Phenotypic spectrum of neurodegeneration associated with mutations in the PLAG6 gene (PLAN). Neurology 70: 1623-1629.
7. 2 produce spermatozoa with impaired motility and have greatly reduced fertility. J Biol Chem 279: 38194-38200.
8. Malik I, Turk J, Mancuso DJ, Montier L, Wohltmann M, et al. (2008) Disrupted Membrane Homeostasis and Accumulation of Ubiquitinated Proteins in a Mouse Model of Infantile Neuroaxonal Dystrophy Caused by PLAG6 Mutations. Am J Pathol 172: 406-416.
9. 2 Deficiency in Mice: A Model of Human Neurodegenerative Disease. J Neurosci 28: 2212-2220.
10. Engel LA, Jing Z, O'Brien DE, Sun M, Kotzbauer PT, (2010) Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism. PLoS One 5: e12897.
11. Barlow JK, Sims KB, Kolodny EH, (1989) Early cerebellar degeneration in twins with infantile neuroaxonal dystrophy. Ann Neurol 25: 413-415.
12. Tanabe Y, Iai M, Ishii M, Tamai K, Maemoto T, et al. (1993) The use of magnetic resonance imaging in diagnosing infantile neuroaxonal dystrophy. Neurology 43: 110-113.
13. Farina L, Nardocci N, Bruzzone MG, D'Incerti L, Zorzi G, et al. (1999) Infantile neuroaxonal dystrophy: neuroradiological studies in 11 patients. Neuroradiology 41: 376-380.
14. Nardocci N, Zorzi G, Farina L, Binelli S, Scaioli W, et al. (1999) Infantile neuroaxonal dystrophy: clinical spectrum and diagnostic criteria. Neurology 52: 1472-1478.
15. Biancheri R, Rossi A, Alpigiani G, Filocamo M, Gandolfo C, et al. (2007) Cerebellar atrophy without cerebellar cortex hyperintensity in infantile neuroaxonal dystrophy (INAD) due to PLAG6 mutation. Eur J Paediatr Neurol 11: 175-177.
16. Carrilho I, Santos M, Guimaraes A, Teixeira J, Chorao R, et al. (2008) Infantile neuroaxonal dystrophy: What's most important for the diagnosis? Eur J Paediatr Neurol.
17. Wu Y, Jiang Y, Gao Z, Wang J, Yuan Y, et al. (2009) Clinical study and PLAG6 mutation screening analysis in Chinese patients with infantile neuroaxonal dystrophy. Eur J Neurol 16: 240-245.
18. Tonelli A, Romaniello R, Grasso R, Cavallini A, Righini A, et al. (2010) Novel splice-site mutations and a large intragenic deletion in PLAG6 associated with a severe and rapidly progressive form of infantile neuroaxonal dystrophy. Clinical Genetics 78: 432-440.
19. Ge Y, Belcher SM, Pierce DR, Light KE, (2004) Detection of Purkinje cell loss following drug exposures to developing rat pups using reverse transcriptase-polymerase chain reaction (RT-PCR) analysis for calbindin-D28k mRNA expression. Toxicology Letters 150: 325-334.
20. Sofroniew MV, Vinters HV, (2010) Astrocytes: biology and pathology. Acta Neuropathol 119: 7-35.
21. Zhang D, Hu X, Qian L, O'Callaghan J, Hong JS, (2010) Astrogliosis in CNS Pathologies: Is There A Role for Microglia? Molecular Neurobiology 41: 232-241.
22. Imai Y, Kohsaka S, (2002) Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia 40: 164-174.
23. Ransohoff RM, Perry VH, (2009) Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 27: 119-145.
24. Block ML, Zecca L, Hong JS, (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8: 57-69.
25. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH, (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140: 918-934.
26. Block ML, Hong JS, (2005) Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 76: 77-98.
27. Marin-Teva JL, Dusart I, Colin C, Gervais A, van Rooijen N, et al. (2004) Microglia promote the death of developing Purkinje cells. Neuron 41: 535-547.
28. Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, et al. (2005) Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 1: 223-232.
29. Trushina E, McMurray CT, (2007) Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 145: 1233-1248.
30. Orrenius S, Gogvadze V, Zhivotovsky B, (2007) Mitochondrial Oxidative Stress: Implications for Cell Death. Annual Review of Pharmacology and Toxicology 47: 143-183.
31. Pope S, Land JM, Heales SJ, (2008) Oxidative stress and mitochondrial dysfunction in neurodegeneration; cardiolipin a critical target? Biochim Biophys Acta 1777: 794-799.
32. 2 and Effects of Metabolic Stress on Glucose Homeostasis. J Biol Chem 281: 20958-20973.
33. 2 Localizes in and Protects Mitochondria during Apoptotic Induction by Staurosporine. J Biol Chem 281: 22275-22288.
34. 2 Results in Insufficient Insulin Secretion and Impaired Glucose Tolerance. Mol Endocrinol 19: 504-515.
35. 2beta-null mice. Am J Physiol Endocrinol Metab 294: E217-229.
36. 2-Mediated Repair of Mitochondrial Membrane Peroxidation. Endocrinology 151: 3038-3048.
37. Subramanian S, Kalyanaraman B, Migrino RQ, (2010) Mitochondrially targeted antioxidants for the treatment of cardiovascular diseases. Recent Pat Cardiovasc Drug Discov 5: 54-65.
38. 2 in cardiolipin remodeling in the spontaneously hypertensive heart failure rat heart. J Lipid Res 51: 525-534.
39. 2 in the pathogenesis of Barth syndrome. Proc Natl Acad Sci U S A 106: 2337-2341.
40. Rivest S, (2009) Regulation of innate immune responses in the brain. Nat Rev Immunol 9: 429-439.
41. Tanaka T, Ueno M, Yamashita T, (2009) Engulfment of axon debris by microglia requires p38 MAPK activity. J Biol Chem 284: 21626-21636.
42. 2, which undergoes proteolytic inactivation. J Biol Chem 273: 13870-13877.
43. Lauber K, Bohn E, Krober SM, Xiao YJ, Blumenthal SG, et al. (2003) Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113: 717-730.
44. Lauber K, Blumenthal SG, Waibel M, Wesselborg S, (2004) Clearance of apoptotic cells: getting rid of the corpses. Mol Cell 14: 277-287.
45. Michlewska S, McColl A, Rossi AG, Megson IL, Dransfield I, (2007) Clearance of dying cells and autoimmunity. Autoimmunity 40: 267-273.
46. Li X, Patel JC, Wang J, Avshalumov MV, Nicholson C, et al. (2010) Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S. J Neurosci 30: 1788-1797.
47. MacKenzie-Graham A, Tiwari-Woodruff SK, Sharma G, Aguilar C, Vo KT, et al. (2009) Purkinje cell loss in experimental autoimmune encephalomyelitis. Neuroimage 48: 637-651.
48. Lee J, Chan SL, Mattson MP, (2002) Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain. Neuromolecular Med 2: 29-45.